These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7063823)

  • 1. [Weight reduction and blood pressure].
    Greminger P; Studer A; Lüscher T; Mutter B; Grimm J; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1982 Jan; 112(4):120-3. PubMed ID: 7063823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reductions of body weight and blood pressure in obese hypertensive patients treated by diet. A retrospective study.
    Novi RF; Porta M; Lamberto M; Molinatti GM
    Panminerva Med; 1989; 31(1):13-5. PubMed ID: 2726283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of low energy diet and weight loss on major risk factors, central obesity and associated disturbances in patients with essential hypertension.
    Singh RB; Niaz MA; Bishnoi I; Singh U; Begum R; Rastogi SS
    J Hum Hypertens; 1995 May; 9(5):355-62. PubMed ID: 7623373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dietary change on the return of hypertension after withdrawal of prolonged antihypertensive therapy (DISH). Dietary Intervention Study of Hypertension.
    Blaufox MD; Langford HG; Oberman A; Hawkins CM; Wassertheil-Smoller SW; Cutter GR
    J Hypertens Suppl; 1984 Dec; 2(3):S179-81. PubMed ID: 6599665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure. The Trials of Hypertension Prevention, phase II. The Trials of Hypertension Prevention Collaborative Research Group.
    Arch Intern Med; 1997 Mar; 157(6):657-67. PubMed ID: 9080920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How useful is weight reduction in the management of hypertension?
    Croft PR; Brigg D; Smith S; Harrison CB; Branthwaite A; Collins MF
    J R Coll Gen Pract; 1986 Oct; 36(291):445-8. PubMed ID: 3440987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension.
    Golan E; Tal B; Dror Y; Korzets Z; Vered Y; Weiss E; Bernheim J
    Isr Med Assoc J; 2002 Jun; 4(6):426-30. PubMed ID: 12073415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of diet and weight reduction in hypertension.
    Singh RB; Rastogi SS; Mehta PJ; Mody R; Garg V
    Nutrition; 1990; 6(4):297-302. PubMed ID: 2134545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compliance with weight reduction in hypertensive patients.
    Ramsay LE
    J Hypertens Suppl; 1985 Apr; 3(1):S81-5. PubMed ID: 3870475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients.
    Reisin E; Abel R; Modan M; Silverberg DS; Eliahou HE; Modan B
    N Engl J Med; 1978 Jan; 298(1):1-6. PubMed ID: 337144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stress-associated hypertension in the work place: results of the STARLET project].
    Lüders S; Hammersen F; Kulschewski A; Frerichs A; Frieg R; Hahnheiser D; Reich G; Schnieders M; Schrandt G; Schrader J
    Dtsch Med Wochenschr; 2006 Nov; 131(46):2580-5. PubMed ID: 17096303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of gastric bypass surgery on hypertension in morbidly obese patients.
    Carson JL; Ruddy ME; Duff AE; Holmes NJ; Cody RP; Brolin RE
    Arch Intern Med; 1994 Jan; 154(2):193-200. PubMed ID: 8285814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
    Toplak H; Ziegler O; Keller U; Hamann A; Godin C; Wittert G; Zanella MT; Zúñiga-Guajardo S; Van Gaal L
    Diabetes Obes Metab; 2005 Nov; 7(6):699-708. PubMed ID: 16219013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure and arm circumference during large weight reduction in normotensive and borderline hypertensive obese patients.
    Andersen T; Stokholm KH; Nielsen PE
    J Clin Hypertens; 1987 Dec; 3(4):547-53. PubMed ID: 3453387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure changes associated with sibutramine and weight management - an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes trial (SCOUT).
    Sharma AM; Caterson ID; Coutinho W; Finer N; Van Gaal L; Maggioni AP; Torp-Pedersen C; Bacher HP; Shepherd GM; James WP;
    Diabetes Obes Metab; 2009 Mar; 11(3):239-50. PubMed ID: 18671798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of orlistat on cardiovascular disease risk in obese adults.
    Swinburn BA; Carey D; Hills AP; Hooper M; Marks S; Proietto J; Strauss BJ; Sullivan D; Welborn TA; Caterson ID
    Diabetes Obes Metab; 2005 May; 7(3):254-62. PubMed ID: 15811142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.